Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Diagnostic Test: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation
(D00998)		[2] Acetylcholine,
Neostigmine		[4] Neostigmine bromide ,
Neostigmine methylsulfate (D00998),
Acetylcholine chloride ,
Neostigmine 💬 		[22] ACHE,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		[18] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Glycerophospholipid metabolism, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬[1] 11 💬
2Neostigmine
(D00998)		[1] Neostigmine[3] Neostigmine bromide ,
Neostigmine methylsulfate (D00998),
Neostigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 11 💬